Related Experiment Videos
Hyporeactivity to interferon induction in newborn piglets.
1University of Guelph, Ontario, Canada.
Summary
Newborn piglets treated with polyinosinic:polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose [poly(ICLC)] become hyporeactive to interferon (IFN) induction. Prostaglandin F2 alpha (PGF2α) treatment restored natural killer (NK) cell activity in these piglets.
Area of Science:
- Immunology
- Virology
- Neonatal Research
Background:
- Natural killer (NK) cells are crucial for innate immunity.
- Interferon (IFN) induction is a key mechanism for activating immune responses.
- Polyinosinic:polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose [poly(ICLC)] is a potent inducer of IFN.
Purpose of the Study:
- To investigate the sustained activation of NK cells in newborn piglets using poly(ICLC).
- To understand the phenomenon of hyporeactivity to IFN induction following repeated poly(ICLC) administration.
- To explore methods for restoring NK cell activity in hyporeactive piglets.
Main Methods:
- Newborn piglets were administered single or multiple doses of poly(ICLC).
- Serum samples were analyzed for hyporeactive factors inhibiting IFN induction.
- Prostaglandin (PG) F2 alpha was administered concurrently with a second dose of poly(ICLC).
- NK cell activity was measured in vivo and in vitro.
Main Results:
- Repeated doses of poly(ICLC) led to hyporeactivity, with insufficient IFN levels to activate NK cells.
- A serum factor inhibiting poly(ICLC)-induced IFN but not Newcastle disease virus-induced IFN was identified in hyporeactive piglets.
- Co-administration of PGF2α with the second poly(ICLC) dose partially restored IFN response and significantly enhanced NK cell activity.
- NK cell activity was higher in PGF2α-treated piglets compared to controls and those receiving poly(ICLC) alone.
Conclusions:
- Piglets develop hyporeactivity to IFN induction after poly(ICLC) treatment.
- The IFN and NK cell activation responses to poly(ICLC) can be restored by PGF2α treatment.
- PGF2α may be a viable strategy to overcome poly(ICLC)-induced immune hyporesponsiveness in neonates.